September 06, 2016
Authored and Edited by Hala S. Mourad; Cory C. Bell
In Praxair Distribution, Inc. v. INO Therapeutics, LLC., IPR2016-00781, Paper 10 (Aug. 25, 2016), the Board denied Praxair’s inter partes review petition based on both estoppel under 35 U.S.C. § 315(e)(1) and the PTAB’s discretion under § 325(d).
The petition challenged the same claims of U.S. Patent No. 8,846,112 as a prior petition filed by Praxair, but based on two new textbook references. Praxair asserted that it did not cite the new references in the earlier IPR because it did not discover them before filing. As evidence, Praxair provided a list of exemplary search results from Cardinal Intellectual Property, Inc.
The Board based its estoppel determination on whether the new references were “prior art which a skilled searcher conducting a diligent search reasonably could have been expected to discover.” The Board found the single search report insufficient to show that a reasonable search was conducted, highlighting the following facts:
The Board also exercised its discretion to deny Praxair’s petition under § 325(d). They reached this conclusion not only because “the same or substantially the same arguments” were previously presented but also because Praxair “should have been aware of the newly-cited . . . references when it filed the earlier Petition.”
America Invents Act (AIA), estoppel, Patent Trial and Appeal Board (PTAB), rules and rules of practice
Copyright © 2016 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Webinar
May 9, 2024
Webinar
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
At the PTAB Blog
USPTO Releases Notice of Proposed Rule Making Codifying Several Precedential Case Factors
April 25, 2024
INCONTESTABLE® Blog
April 19, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.